AIM Vaccine Co., Ltd. (HKG:6660)
Hong Kong · Delayed Price · Currency is HKD 1.680
+0.040 (2.44%)
Jul 10, 2026, 10:50 AM HKT
AIM Vaccine Market Cap
AIM Vaccine has a market cap or net worth of 2.01 billion as of July 9, 2026. Its market cap has decreased by -57.29% in one year.
Market Cap
2.01B
Enterprise Value
3.77B
Revenue
1.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
1.68
Market Cap Chart
Since October 6, 2022, AIM Vaccine's market cap has decreased from 20.15B to 2.01B, a decrease of -90.02%. That is a compound annual growth rate of -45.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 2.01B | -48.91% |
| Dec 31, 2025 | 3.94B | -47.05% |
| Dec 31, 2024 | 7.44B | -21.78% |
| Dec 29, 2023 | 9.51B | -67.02% |
| Dec 30, 2022 | 28.82B | 43.02% |
| Oct 6, 2022 | 20.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TYK Medicines | 2.60B |
| Viva Biotech Holdings | 2.54B |
| Beijing Luzhu Biotechnology | 2.53B |
| HJ Science | 2.50B |
| Clover Biopharmaceuticals | 2.22B |
| Frontage Holdings | 2.17B |
| PegBio | 2.15B |
| Mabpharm | 1.75B |